Tetradecyl Thioacetic Acid - NutraPedia

Back to Table of Contents

Tetradecyl Thioacetic Acid (TTA)

1) Conditions Studied for Tetradecyl Thioacetic Acid

Tetradecyl Thioacetic Acid has been studied for various metabolic conditions, particularly:

Obesity and weight management
Diabetes and insulin sensitivity
Dyslipidemia (abnormal lipid levels)
Inflammatory conditions

2) Efficacy in Treating Studied Conditions

The efficacy of TTA in treating the aforementioned conditions is still under investigation. Some studies suggest that TTA:

May reduce body fat mass by enhancing fatty acid oxidation
Could improve insulin sensitivity in animal models
May have potential in managing blood lipid levels
Has shown anti-inflammatory properties in some research

3) Health Benefits of Tetradecyl Thioacetic Acid

Some proposed health benefits of TTA include:

Modulation of lipid metabolism
Possible improvement of insulin sensitivity
Reduction in inflammation markers
Potential antioxidant effects

4) Downsides of Tetradecyl Thioacetic Acid

While TTA may offer health benefits, it also has potential downsides:

Further research is required to confirm its safety and efficacy
Long-term effects are not well-understood
Possible side effects have not been thoroughly studied

5) Genetic Variations and Tetradecyl Thioacetic Acid

There is limited information on whether TTA is particularly beneficial or harmful for specific genetic variations. However, individual responses to TTA may vary due to:

Genetic factors affecting lipid metabolism and insulin sensitivity
Genetic predispositions to obesity or other metabolic disorders
Differences in absorption and metabolism of TTA

Further research is necessary to clarify the role of genetic variations in response to TTA supplementation.

Research Summary on Tetradecylthioacetic Acid (TTA)

Tetradecylthioacetic Acid (TTA) is a sulfur-substituted fatty acid analogue known for its hypolipidemic and anti-inflammatory effects, as well as its ability to activate peroxisome proliferator-activated receptors (PPARs). Studies have shown that TTA can influence metabolic processes, lipid metabolism, and mitochondrial function.

TTA's Activation of PPARs and Metabolic Effects

TTA activates PPAR subtypes, especially PPARalpha and PPARgamma, with chain lengths up to C14 showing increased activation effects.
Alpha-methylated derivatives of TTA showed stronger activation of PPARalpha, enhancing the expression of target genes involved in fatty acid metabolism.
TTA's lipid-lowering effects in the liver do not require PPARalpha, with PPARdelta activation also playing a key role.
In CaCo-2 cells, TTA reduces triacylglycerol secretion without affecting the synthesis induced by oleic acid or the general secretory process.

TTA in Health Conditions

TTA improves heart function in type 2 diabetic mice and increases the breakdown of fatty acids in the liver without PPARalpha.
While it reduces triacylglycerol secretion in CaCo-2 cells, TTA does not alter apolipoprotein B secretion or microsomal triacylglycerol transfer protein activity.
TTA has been demonstrated to reduce plasma triacylglycerol levels and positively alter fatty acid composition in the liver of mice with chronic inflammation.
Topical application of TTA did not show significant improvement in plaque psoriasis symptoms in a small-scale study.
In cardiac function studies, TTA reduced efficiency in normal mice but improved tolerance to low oxygen conditions in diabetic mice.

TTA's Potential Therapeutic Uses

TTA may have therapeutic potential for inflammatory disorders, obesity, insulin resistance, and cardiovascular diseases due to its various effects on lipid metabolism and fatty acid oxidation.
Long-term treatment with TTA alters heart fatty acid composition and lipid metabolism, with distinct effects from those in the liver.
TTA induces mitochondrial biogenesis and enhances respiration in rat hepatocytes, not solely through PPAR activation.
TTA's hypolipidemic and anti-inflammatory properties could be beneficial for psoriasis patients, as it lowers lipid levels and inflammatory markers.
In hypertensive rats, TTA effectively reduced high blood pressure and prevented organ damage while improving lipid metabolism.
Combining TTA with a cholesterol-lowering diet showed promising results in managing dyslipidemia and inflammation in HIV patients on HAART.

Conclusion

TTA is a fatty acid analogue with significant effects on fatty acid metabolism, PPAR activation, and potential benefits for various health conditions. However, further research is needed to confirm its therapeutic efficacy and safety.

References:

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!